CoChat
Sign Up
Cited by 18

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study

Roux, Perrine, Donadille, Cécile, Magen, Carine, Schatz, Eberhard, Stranz, Richard, Curado, Adriana, Tsiakou, Tania, Verdes, Ludmila, Aleksova, Aleksandrina, Carrieri, Patrizia, Mezaache, Salim, Charif Ali, Ben·2021·International Journal of Drug Policy
DOI 10.1016/j.drugpo.2020.102992
Open this paper in CoChat — free account

Abstract

Background Harm reduction (HR) interventions are essential to reduce human immunodeficiency virus (HIV) and hepatitis C virus (HCV) transmission in people who inject drugs (PWID). Preliminary testing of the Individually Tailored Support and Education for Safer Injection (ITSESI) evidence-based educational intervention for PWID was performed in France in 2011. We created the Eurosider project to implement and evaluate ITSESI at a wider European level, with a view to its future pan-European diffusion. Methods We performed a mixed-methods study involving quantitative (a 6-month before-after study with PWID) and qualitative (focus groups with field workers) components. The study was conducted in 2018-2019 with 307 eligible PWID participating in four existing HR programmes in Bulgaria, Greece, Portugal, and Romania. ITSESI consists in trained field workers observing PWID injection practices and providing an educational exchange. For the present study, PWID participants were allocated to either the control group (i.e., they continued receiving only the current HR services) or the intervention group (i.e., current HR services plus ITSESI). We used the RE-AIM QuEST framework to assess the effectiveness of ITSESI and its acceptability by field workers. Effectiveness was defined as a reduction in both syringe sharing - the highest HIV/HCV transmission risk practice - and in cutaneous abscesses. We used a multivariable mixed logit model to analyse both effectiveness outcomes and to prov…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.drugpo.2020.102992

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 35

  1. Arendt, 2019, Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg, PloS One, 14, 10.1371/journal.pone.0215570 · DOI
  2. Bell, 2017, Supervised Injectable Heroin: A Clinical Perspective, Can J Psychiatry Rev Can Psychiatr, 62, 451, 10.1177/0706743716673966 · DOI
  3. Ben Charif, 2018, Assessment of scalability of evidence-based innovations in community-based primary health care: a cross-sectional study, CMAJ Open, 6, E520, 10.9778/cmajo.20180143 · DOI
  4. Braun, 2014, What can ‘thematic analysis’ offer health and wellbeing researchers?, Int J Qual Stud Health Well-Being, 9, 26152, 10.3402/qhw.v9.26152 · DOI · Paper page
  5. Cherubin, 1993, The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later, Ann Intern Med, 119, 1017, 10.7326/0003-4819-119-10-199311150-00009 · DOI · Paper page
  6. Degenhardt, 2013, Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia, Drug Alcohol Rev, 32, 468, 10.1111/dar.12066 · DOI
  7. Dwyer, 2009, Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users, Drug Alcohol Depend, 100, 9, 10.1016/j.drugalcdep.2008.08.016 · DOI · Paper page
  8. 2011, European Monitoring Centre for Drugs and Drug Addiction. Prevention and control of infectious diseases among people who inject drugs: guidance in brief, European Centre for Disease Prevention and Control : European Monitoring Centre for Drugs and Drug Addiction
  9. Forman, 2017, Development and application of the RE-AIM QuEST mixed methods framework for program evaluation, Prev Med Rep, 6, 322, 10.1016/j.pmedr.2017.04.002 · DOI
  10. Glasgow, 2019, RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review, Front Public Health, 7, 64, 10.3389/fpubh.2019.00064 · DOI · Paper page
  11. Gountas, 2019, Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals, World J Gastroenterol, 25, 1327, 10.3748/wjg.v25.i11.1327 · DOI
  12. Hartman, 2016, Opiate Injection-associated Infective Endocarditis in the Southeastern United States, Am J Med Sci, 352, 603, 10.1016/j.amjms.2016.08.010 · DOI
  13. Hawk, 2017, Harm reduction principles for healthcare settings, Harm Reduct J, 14, 70, 10.1186/s12954-017-0196-4 · DOI · Paper page
  14. Hope, 2014, Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities, Int J Drug Policy, 25, 303, 10.1016/j.drugpo.2013.11.012 · DOI
  15. Hopwood, 2003, The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment, Aust N Z J Public Health, 27, 551, 10.1111/j.1467-842X.2003.tb00832.x · DOI
  16. Horyniak, 2013, The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs, Drug Alcohol Depend, 132, 541, 10.1016/j.drugalcdep.2013.03.021 · DOI
  17. Huang, 2006, Evaluation of PICO as a Knowledge Representation for Clinical Questions, AMIA Annu Symp Proc, 2006, 359
  18. Hunter, 2018, Safe and unsafe spaces: non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City, Int J Drug Policy, 57, 25, 10.1016/j.drugpo.2018.03.026 · DOI
  19. Jones, 2010, Optimal provision of needle and syringe programmes for injecting drug users: A systematic review, Int J Drug Policy, 21, 335, 10.1016/j.drugpo.2010.02.001 · DOI
  20. Kerr, 2005, High rates of primary care and emergency department use among injection drug users in Vancouver, J Public Health Oxf Engl, 27, 62, 10.1093/pubmed/fdh189 · DOI · Paper page
  21. Khatmi, 2018, Impact of an educational intervention on risks associated with drug injection, and on psychosocial factors (PSF) involved in initiating and maintaining new health behaviors over time, Addict Behav, 87, 222, 10.1016/j.addbeh.2018.07.007 · DOI
  22. Latkin, 1974, Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks, Public Health Rep Wash DC, 113, 151
  23. Maisa, 2019, Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016-2017, J Viral Hepat, 26, 1377, 10.1111/jvh.13184 · DOI
  24. Palmateer, 2010, Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews, Addict, 105, 844, 10.1111/j.1360-0443.2009.02888.x · DOI
  25. Palmateer, 2013, Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe, Int J Drug Policy, 24, 85, 10.1016/j.drugpo.2012.08.006 · DOI
  26. Pascual-Argente, 2018, Non-healthcare costs of hepatitis C: a systematic review, Expert Rev Gastroenterol Hepatol, 12, 19, 10.1080/17474124.2017.1373016 · DOI
  27. Platt, 2017, Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs, Cochrane Database Syst Rev, 18
  28. Roux, 2016, Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study, Addict, 111, 94, 10.1111/add.13089 · DOI
  29. Roux, 2016, Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study, PloS One, 11, 10.1371/journal.pone.0157062 · DOI
  30. Sacks-Davis, 2012, Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review, Int J Drug Policy, 23, 176, 10.1016/j.drugpo.2011.08.002 · DOI
  31. Shelton, 2003, Comparing longitudinal binary outcomes in an observational oral health study, Stat Med, 22, 2057, 10.1002/sim.1469 · DOI
  32. Topp, 2013, Housing Instability among People Who Inject Drugs: Results from the Australian Needle and Syringe Program Survey, J Urban Health Bull N Y Acad Med, 90, 699
  33. 2018, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users – 2012 revision [Internet], WHO
  34. Wilson, 2015, The cost-effectiveness of harm reduction, Int J Drug Policy, 26, S5, 10.1016/j.drugpo.2014.11.007 · DOI
  35. Yoshida, 2013, Obtaining subjects’ consent to publish identifying personal information: current practices and identifying potential issues, BMC Med Ethics, 14, 47, 10.1186/1472-6939-14-47 · DOI

Cited by

Sorted by citations

Metadata

Authors
Roux, P., Donadille, C., Magen, C., Schatz, E., Stranz, R., Curado, A., Tsiakou, T., Verdes, L., Aleksova, A., Carrieri, P., Mezaache, S., & Charif Ali, B.
Venue
International Journal of Drug Policy
Publisher
Elsevier BV
Published
2021-01
Volume
87
Pages
102992
ISSN
0955-3959
DOI
10.1016/j.drugpo.2020.102992
Cited by
18
References
3
Language
en
Licence
Funders
European Commission

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review